Further studies analyzing serum samples from patients with varying NASH severities may help further confirm the role of ASC, IL-18, and Gal-3 as inflammatory biomarkers for this condition. The gene discussed is IL18; the disease is metabolic dysfunction-associated steatohepatitis.